Taste Acuity and Caloric Intake After Acute Morphine Administration
NCT01763697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2014-05-29
Summary
This study will investigate the effects of acute morphine administration on taste acuity and how much a person eats. It is hypothesized that there will be a dose dependent decrease in taste acuity and dose dependent increase in food intake associated with acute morphine administration. Knowledge from this study will impact the future of feeding behavior and obesity research in the general population. Results will also promote exploration of the long-term effect of opioid abuse on taste acuity and feeding behavior in substance abusing populations.
Conditions
- Taste Sweet
- Taste Salty
- Feeding Behavior
Interventions
- BEHAVIORAL
-
taste acuity assessment
Quantitative measurement of for tasting detection and recognition thresholds, magnitude of perception and hedonic response.
- BEHAVIORAL
-
Recorded meal
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Denis G Antoine, M.D. · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects
NCT04683926 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)
NCT00474799 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT02446561 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol
NCT03164512 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
NCT01717027 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02117583 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers
NCT00973232 ·Status: COMPLETED ·Phase: PHASE1
-
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
NCT03809507 ·Status: COMPLETED
-
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532 ·Status: COMPLETED ·Phase: PHASE4
-
Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
NCT03248765 ·Status: TERMINATED
-
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926 ·Status: COMPLETED ·Phase: NA
-
Environment Analysis Inside an Investigational Prescription Bottle
NCT03752411 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Nalbuphine Injection
NCT03826316 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4
-
Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain
NCT02824276 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
NCT00952068 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
NCT06902103 ·Status: COMPLETED ·Phase: PHASE1
-
Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes
NCT02932579 ·Status: TERMINATED ·Phase: PHASE4
-
Cannabidiol, Morphine, Pain
NCT04030442 ·Status: RECRUITING ·Phase: PHASE1
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.
NCT02133820 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Oral Morphine and Pharmacogenomics of CYP2D6 and UGT2B7, in an Urban Pediatric Population Presenting for Elective Surgery
NCT01071499 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
NCT05049733 ·Status: COMPLETED ·Phase: PHASE1
-
QTc and Perceived Sleep Follow up Among Chronic Pain Patients With Opiate Medication
NCT00999440 ·Status: UNKNOWN ·Phase: NA
-
Immediate-Release Oxycodone Capsules Study in Cancer Pain
NCT01675622 ·Status: COMPLETED ·Phase: PHASE3